Therefore, it is also important to note that the synergistic effect of the combination therapy may be due both to the inherent radiosensitivity of HNSCC cells and to the levels of CD98hc expression on the cell surface, which can be modulated by radiation treatment. This evidence concerns the gene SLC3A2 and head and neck squamous cell carcinoma.